Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

ovarian cancer

  • Open Access
    Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?
    ANAS BARAKAT, AEMN ISMAIL, QUENTIN DAVIES and SUPRATIK CHATTOPADHYAY
    In Vivo July 2022, 36 (4) 1834-1840; DOI: https://doi.org/10.21873/invivo.12900
  • Open Access
    Survival Outcomes With Reduced Doses of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
    JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG
    In Vivo July 2022, 36 (4) 1868-1874; DOI: https://doi.org/10.21873/invivo.12905
  • Open Access
    Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer
    JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG, NAN YOUNG LEE, IN HEE LEE, JI YOUNG PARK and DAE GY HONG
    In Vivo July 2022, 36 (4) 1903-1910; DOI: https://doi.org/10.21873/invivo.12910
  • Open Access
    The Impact of COVID-19 Infection During the Postoperative Period After Surgery for Ovarian Cancer
    NICOLAE BACALBASA and IRINA BALESCU
    In Vivo May 2022, 36 (3) 1337-1341; DOI: https://doi.org/10.21873/invivo.12835
  • You have access
    Hypoxia-induced Maspin Expression Affects the Prognosis of Ovarian Clear Cell Carcinoma
    EUN JI LEE, SOO JIN PARK, CHEOL LEE, GA WON YIM, JAE WEON KIM and HEE SEUNG KIM
    In Vivo January 2022, 36 (1) 212-220; DOI: https://doi.org/10.21873/invivo.12693
  • You have access
    Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies
    MIKLOS ACS, HUBERT LEEBMANN, SEBASTIAN HÄUSLER, PHILIPP HARTER and POMPILIU PISO
    In Vivo January 2022, 36 (1) 341-349; DOI: https://doi.org/10.21873/invivo.12708
  • You have access
    Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    MIKLOS ACS, SEBASTIAN HÄUSLER, HAMID-REZA LIGHVANI, JOZEF ZUSTIN and POMPILIU PISO
    In Vivo November 2021, 35 (6) 3591-3596; DOI: https://doi.org/10.21873/invivo.12664
  • You have access
    SERPINB11 Expression Is Associated With Prognosis of High-grade Serous and Clear Cell Carcinoma of the Ovary
    SOO JIN PARK, WHASUN LIM, JAEHEE MUN, HAERIN PAIK, SUNWOO PARK, HYUNJI LIM, JUNHWAN KIM, EUN JI LEE, GA WON YIM, NARA LEE, CHEOL LEE, JAE-WEON KIM, GWONHWA SONG and HEE SEUNG KIM
    In Vivo September 2021, 35 (5) 2647-2653; DOI: https://doi.org/10.21873/invivo.12547
  • You have access
    Areas to Improve Quality of Life After Ovarian Tumor Surgery and Adjuvant Treatment
    ARTURAS DOBILAS, LOUISE MOBERG and CHRISTER BORGFELDT
    In Vivo July 2021, 35 (4) 2399-2408; DOI: https://doi.org/10.21873/invivo.12517
  • You have access
    Risk Factors for Severe Complications in Ovarian Cancer Surgery
    EVA KATHARINA EGGER, NATASCHA KOHLS, MATTHIAS B. STOPE, MATEJA CONDIC, MIGNON-DENISE KEYVER-PAIK, DOMINIQUE KÖNSGEN, TOBIAS HILBERT, SVEN KLASCHIK, DANIEL EXNER, TIM VILZ and ALEXANDER MUSTEA
    In Vivo November 2020, 34 (6) 3361-3365; DOI: https://doi.org/10.21873/invivo.12174

Pages

  • Next
  • 1
  • 2
  • 3
In Vivo

© 2022 In Vivo

Powered by HighWire